Date Filed | Type | Description |
03/06/2023 |
4
| HUTT PETER BARTON (Director) has filed a Form 4 on CONCERT PHARMACEUTICALS, INC.
Txns:
| Unknown transaction of 13,088 shares
@ $0 Disposed/sold 16,400 shares
@ $0 Disposed/sold 10,000 options to buy
@ $16.42, valued at
$164.2k
Disposed/sold 10,000 options to buy
@ $12.96, valued at
$129.6k
Disposed/sold 10,000 options to buy
@ $13.29, valued at
$132.9k
Disposed/sold 10,000 options to buy
@ $19.59, valued at
$195.9k
Disposed/sold 10,000 options to buy
@ $11.02, valued at
$110.2k
Disposed/sold 10,000 options to buy
@ $9.16, valued at
$91.6k
Disposed/sold 10,250 options to buy
@ $4.26, valued at
$43.7k
|
|
10/18/2022 |
4
| HUTT PETER BARTON (Director) has filed a Form 4 on CONCERT PHARMACEUTICALS, INC.
Txns:
| Sold 3,539 shares
@ $6.09, valued at
$21.6k
Exercised 3,539 options to buy
@ $2.88, valued at
$10.2k
|
|
06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/23/2020 |
4
| HUTT PETER BARTON (Director) has filed a Form 4 on IMMUNOMEDICS INC
Txns:
| Disposed/sold 13,516 shares
@ $0 Disposed/sold 52,614 options to buy
@ $0 Disposed/sold 3,718 restricted stock units
@ $0 |
|
09/01/2020 |
4
| HUTT PETER BARTON (Director) has filed a Form 4 on CONCERT PHARMACEUTICALS, INC.
Txns:
| Exercised 3,539 options to buy
@ $3.79, valued at
$13.4k
|
|
06/22/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/12/2020 |
4
| HUTT PETER BARTON (Director) has filed a Form 4 on CONCERT PHARMACEUTICALS, INC.
Txns:
| Granted 10,000 options to buy
@ $9.16, valued at
$91.6k
|
|
11/22/2019 |
4
| HUTT PETER BARTON (Director) has filed a Form 4 on Moderna, Inc.
Txns:
| Sold 200,000 shares
@ $20.18, valued at
$4M
Exercised 200,000 options to buy
@ $0.04, valued at
$8k
|
|
09/18/2019 |
4
| HUTT PETER BARTON (Director) has filed a Form 4 on Moderna, Inc.
Txns:
| Sold 100,000 shares
@ $17.63, valued at
$1.8M
Exercised 100,000 options to buy
@ $0.04, valued at
$4k
|
|
08/12/2019 |
4
| HUTT PETER BARTON (Director) has filed a Form 4 on CONCERT PHARMACEUTICALS, INC.
Txns:
| Sold 3,539 shares
@ $10.31, valued at
$36.5k
Exercised 3,539 options to buy
@ $4.41, valued at
$15.6k
|
|
06/28/2019 |
4
| HUTT PETER BARTON (Director) has filed a Form 4 on Moderna, Inc.
Txns:
| Granted 54,660 options to buy
@ $14.34, valued at
$783.8k
|
|
06/17/2019 |
4
| HUTT PETER BARTON (Director) has filed a Form 4 on CONCERT PHARMACEUTICALS, INC.
Txns:
| Granted 10,000 options to buy
@ $11.02, valued at
$110.2k
|
|
06/11/2019 |
4
| HUTT PETER BARTON (Director) has filed a Form 4 on IMMUNOMEDICS INC
Txns:
| Granted 9,667 shares
@ $0 Granted 17,077 options to buy
@ $12.93, valued at
$220.8k
|
|
12/07/2018 |
3
| HUTT PETER BARTON (Director) has filed a Form 3 on Moderna, Inc. |
09/18/2018 |
4
| HUTT PETER BARTON (Director) has filed a Form 4 on IMMUNOMEDICS INC
Txns:
| Granted 3,849 shares
@ $0 Granted 6,497 options to buy
@ $14.29, valued at
$92.8k
|
|
07/26/2018 |
4
| HUTT PETER BARTON (Director) has filed a Form 4 on Flex Pharma, Inc.
Txns:
| Granted 10,000 options to buy
@ $0.82, valued at
$8.2k
|
|
06/19/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/18/2018 |
4
| HUTT PETER BARTON (Director) has filed a Form 4 on CONCERT PHARMACEUTICALS, INC.
Txns:
| Granted 10,000 options to buy
@ $19.59, valued at
$195.9k
|
|
07/27/2017 |
4
| HUTT PETER BARTON (Director) has filed a Form 4 on Flex Pharma, Inc.
Txns:
| Granted 12,000 options to buy
@ $4.08, valued at
$49k
|
|
07/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/20/2017 |
4
| HUTT PETER BARTON (Director) has filed a Form 4 on SELECTA BIOSCIENCES INC
Txns:
| Granted 6,410 options to buy
@ $17.47, valued at
$112k
|
|
06/19/2017 |
4
| HUTT PETER BARTON (Director) has filed a Form 4 on CONCERT PHARMACEUTICALS, INC.
Txns:
| Granted 10,000 options to buy
@ $13.29, valued at
$132.9k
|
|
05/22/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
03/23/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
11/21/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
08/30/2016 |
4
| HUTT PETER BARTON (Director) has filed a Form 4 on DNIB UNWIND, INC. |
08/02/2016 |
4
| HUTT PETER BARTON (Director) has filed a Form 4 on XOMA Corp
Txns:
| Granted 121,064 options to buy
@ $0.5599, valued at
$67.8k
|
|
06/22/2016 |
4
| HUTT PETER BARTON (Director) has filed a Form 4 on BIND Therapeutics, Inc
Txns:
| Granted 15,000 options to buy
@ $0.44, valued at
$6.6k
|
|
06/21/2016 |
3
| HUTT PETER BARTON (Director) has filed a Form 3 on SELECTA BIOSCIENCES INC |
06/17/2016 |
4
| HUTT PETER BARTON (Director) has filed a Form 4 on Seres Therapeutics, Inc.
Txns:
| Granted 15,000 options to buy
@ $30.24, valued at
$453.6k
|
|
06/10/2016 |
4
| HUTT PETER BARTON (Director) has filed a Form 4 on CONCERT PHARMACEUTICALS, INC.
Txns:
| Granted 10,000 options to buy
@ $12.96, valued at
$129.6k
|
|
06/09/2016 |
4
| HUTT PETER BARTON (Director) has filed a Form 4 on Flex Pharma, Inc.
Txns:
| Granted 10,000 options to buy
@ $12.21, valued at
$122.1k
|
|
07/01/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|